Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Skin Neoplasms × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Colorectal Neoplasms 2 Skin Neoplasms 1 Skin Diseases 1 Rectal Neoplasms 1 Rectal Diseases 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colonic Neoplasms 1 Colonic Diseases 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

encorafenib 1 binimetinib 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01909453 2026-02-27

COLUMBUS

Pfizer

Phase 3 Completed

921 enrolled 48 charts 1 FDA

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡